A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Alcon Research0 个研究点目标入组 173 人2004年7月

适应症Open-Angle Glaucoma Ocular Hypertension

干预措施Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution Timolol Vehicle Latanoprost 0.005% Ophthalmic Solution (XALATAN)Timolol 0.5% Ophthalmic Solution

概览

阶段: 3 期
干预措施: Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution
疾病 / 适应症: Open-Angle Glaucoma
发起方: Alcon Research
入组人数: 173
主要终点: Mean Intraocular Pressure (IOP) Change at 3 Months from Baseline
状态: 已完成
最后更新: 14年前

概览研究者入排标准研究组 & 干预措施结局指标相似试验

概览

简要总结

The purpose of the study is to evaluate the safety and effectiveness of an investigational glaucoma therapy in patients with open-angle glaucoma or ocular hypertension.

注册库

clinicaltrials.gov

开始日期

2004年7月

结束日期

2005年12月

最后更新

14年前

研究类型

Interventional

研究设计

Parallel

性别

All

研究者

发起方

Alcon Research

责任方

Sponsor

入排标准

入选标准

•18 years or older.
•Diagnosis of open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension.
•Mean intraocular pressure (IOP) in at least one eye greater than 21 mmHg and less than or equal to 36 mmHg at screening visit.
•Other protocol-defined inclusion criteria may apply.

排除标准

•History of chronic or recurrent severe inflammatory eye disease.
•History of ocular infection or ocular inflammation within the past three months in either eye.
•Other protocol-defined exclusion criteria may apply.

研究组 & 干预措施

Travoprost/Timolol

One drop Travoprost 0.004%/Timolol 0.5% in the study eye(s) each morning at 8 a.m. and one drop Timolol vehicle in the study eye(s) each evening at 8 p.m. for 3 months

干预措施: Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution

Travoprost/Timolol

One drop Travoprost 0.004%/Timolol 0.5% in the study eye(s) each morning at 8 a.m. and one drop Timolol vehicle in the study eye(s) each evening at 8 p.m. for 3 months

干预措施: Timolol Vehicle